Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal desmopressin for prevention of bleeding complications after kidney biopsy
IRCT20201019049075N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of desmopressin in Bleeding (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Proportion of patients who develop hematoma and Proportion of patients who develop hematuria. Started Apr 2019; status: completed.
02
Drugs
desmopressin
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20201019049075N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201019049075N2.